Talabostat Completed Phase 2 Trials for Melanoma / Skin Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00083252Study of Talabostat and Cisplatin in Advanced Melanoma
NCT00083239Study of Talabostat in Advanced Melanoma